FindTrial
Sign In

Effect of Zolendronate in patients of celiac disease

To study the effect of Zoledronate on the bone mineral density in adult celiac disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005863
Enrollment
50
Registered
2015-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of celiac disease

Interventions

Intervention1: Zolendronate vs placebo: Fifty subjects were recruited at baseline, out of which 34 completed the study. All the subjects underwent BMD measurements at lumbar spine and subjects with lo

Sponsors

Dr Sanjay Kumar Bhadada
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed adult celiac disease patients aged >=18yrs attending the outpatient departments of Endocrinology and Gastroenterology were recruited and followed prospectively for one year

Exclusion criteria

Exclusion criteria: pregnant or expected pregnant patients, patients less than 18 years of the age, patients on other drugs that can interfere on BMD or patients with other bone diseases

Design outcomes

Primary

MeasureTime frame
change in Bone Mineral Density (BMD)Timepoint: 3, 6 and 12 months—

Secondary

MeasureTime frame
Improvement in metabolic disease parametersTimepoint: 3,6 and 12 months—

Countries

India

Contacts

Public ContactDr Mukul Kumar

Postgraduate Institute of Medical Education and Research

bhadadask@rediffmail.com9814703760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026